10 LIVROS EM INGLÊS RELACIONADOS COM «NEPHROPATHIC»
Descubra o uso de
nephropathic na seguinte seleção bibliográfica. Livros relacionados com
nephropathic e pequenos extratos deles para contextualizar o seu uso na literatura.
1
Inborn Metabolic Diseases: Diagnosis and Treatment
Gahl WA, Kaiser-Kupfer MI (1987) Complications of nephropathic cystinosis after
renal failure. Pediat Nephrol 1:260-268 6. Geelen JM, Monnens LA, Levtchenko
EN (2002) Follow-up and treatment of adults with cystinosis in the Netherlands.
John Fernandes, Jean-Marie Saudubray, Georges van den Berghe, 2006
Treatment with recombinant human growth hormone in short children with
nephropathic cystinosis: no evidence for increased deterioration rate of renal
function. Pediatr Res 1998;43:484–488. Gahl WA, Schneider JA, Thoene JG,
Chesney R.
Ellis D. Avner, William E. Harmon, Patrick Niaudet, 2009
3
Molecular and Genetic Basis of Renal Disease
Vester U, Schubert M,Offner G, Brodehl J: Distal myopathy in nephropathic
cystinosis.Pediatr Nephrol 14:36–38,2000. 37. Sonies BC,Almajid P, Kleta R,et al
: Swallowing dysfunction in 101 patients with nephropathic cystinosis: Benefit of ...
David B. Mount, Martin R. Pollak, 2008
4
Cognitive and Behavioral Abnormalities of Pediatric Diseases
CONCLUSION Nephropathic cystinosis is a multisystem disorder that is
associated with specific cognitive and neurological impairments. The cognitive
changes include difficulties with visuospatial skills, arithmetic, mental rotation,
and ...
Ruth D. Nass, Yitzchak Frank, 2010
5
Type 2 Diabetes: New Insights for the Healthcare ...
The present study was aimed to examine the serum levels of IL-17A and IFN-
gamma as antagonistic cytokines in nephropathic and non-nephropathic type-2
diabetic patients.” “In this experimental study, serum samples were obtained from
...
6
Evidence-Based Nephrology
16 Bradbury JA, Danjoux JP, Voller J, Spencer M, Brocklebank T. A randomised
placebo-controlled trial of topical cysteamine therapy in patients with
nephropathic cystinosis. Eye 1991; 5(6): 755–760. 17 Iwata F, Kuehl EM, Reed
GF, McCain ...
Donald A. Molony, M.D., Jonathan C. Craig, 2011
7
Organelles: Advances in Research and Application: 2011 Edition
Current study results from the report, 'Mitochondrial autophagy promotes cellular
injury in nephropathic cystinosis,' have been published. “The molecular and
cellular mechanisms underlying nephropathic cystinosis, which exhibits
generalized ...
8
Subcellular Fractions: Advances in Research and Application: ...
Stanford University School of Medicine: Abnormal mitochondrial autophagy in
nephropathic cystinosis New research, 'Abnormal mitochondrial autophagy in
nephropathic cystinosis,' is the subject of a report. According to recent research
from ...
9
Copeland and Afshari's Principles and Practice of Cornea
Age-related prevalence of anterior segment complications in patients with
infantile nephropathic cystinosis. Cornea. 2002;21(2):173-6. Cotran PR, Bajart
AM. Congenital corneal opacities. Int Ophthalmol Clin. 1992;32(1):93—105. Katz
B ...
10
Physician's Guide to the Treatment and Follow-Up of ...
(1991) Renal transplantation in 22 children with nephropathic cystinosis. Pediat
Nephrol 5:708–714 Gahl WA, Reed GF, Thoene JG, et al. (1987) Cysteamine
therapy for children with nephropathic cystinosis. N Engl J Med 316:971–977
Gahl ...
Nenad Blau, Georg F. Hoffmann, J.V. Leonard, 2006
10 NOTÍCIAS NAS QUAIS SE INCLUI O TERMO «NEPHROPATHIC»
Conheça de que se fala nos meios de comunicação nacionais e internacionais e como se utiliza o termo
nephropathic no contexto das seguintes notícias.
Pre-Market News Alert on: Cognizant Technology Solutions …
The company offers PROCYSBI, a delayed-release capsule, which is used for the administration of nephropathic cystinosis in adults, ... «wsnewspublishers, jul 15»
Leerink Swann Boosts Raptor Pharmaceutical Corp. Price Target to …
... PROCYSBI delayed-release capsules, received marketing approval from the FDA for the management of nephropathic cystinosis in adults ... «Mideast Time, jul 15»
Raptor Pharmaceutical Announces Management Changes
With an approved product in the U.S. and EU, Raptor also holds several orphan drug designations, including exclusivity for nephropathic ... «MarketWatch, jul 15»
Why Cheetah Mobile (CMCM), Raptor Pharmaceutical (RPTP) and …
RPTP, which is marketing its Procysbi treatment for nephropathic cystinosis, is said to be a likely acquisition candidate going forward. However ... «Investorplace.com, jul 15»
Investment Analysts' Downgrades for July, 8th (INSY, INVVY, INWK …
Raptor currently has product candidates in clinical development designed to treat nephropathic cystinosis, non-alcoholic steatohepatitis ... «sleekmoney, jul 15»
Trader's Buzzers- Raptor Pharmaceutical Corp (RPTP), Rex Energy …
The company offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults, as well as ... «Investor Wired, jul 15»
Raptor Pharmaceutical Corp. Lowered to "Underperform" at …
... PROCYSBI delayed-release capsules, received marketing approval from the FDA for the management of nephropathic cystinosis in adults ... «Dakota Financial News, jul 15»
Zacks Lowers Raptor Pharmaceutical Corp. to Hold (RPTP)
Raptor currently has product candidates in clinical development designed to treat nephropathic cystinosis, non-alcoholic steatohepatitis ... «The Legacy, jun 15»
Investment Analysts' Downgrades for June, 26th (CHA, DTLK, EGAN …
Raptor currently has product candidates in clinical development designed to treat nephropathic cystinosis, non-alcoholic steatohepatitis ... «Mideast Time, jun 15»
Thomas Daley Unloaded 35000 Shares of Raptor Pharmaceutical …
... PROCYSBI delayed-release capsules, received marketing approval from the FDA for the management of nephropathic cystinosis in adults ... «OctaFinance.com, jun 15»
